logo

Shariah compliance overview

Halal

Acadia Pharmaceuticals Inc. (ACAD) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc. operates as a biopharmaceutical company, primarily dedicated to discovering, developing, and commercializing small molecule therapeutics. Their core focus lies in addressing critical unmet medical needs within the realm of central nervous system (CNS) disorders.

Acadia Pharmaceuticals Inc. (ACAD) operates in the Healthcare sector, in the Biotechnology industry.

Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 2.88% (limit 5%), interest-bearing debt is 0.33% (limit 30%) and interest-bearing securities and assets are 23.14% (limit 30%).

If you hold ACAD, give 2.88% of the dividends you receive to charity to purify the non-compliant share of its income.

Business Activity
2.88%Limit 5%Pass
Interest-bearing debt
0.33%Limit 30%Pass
Interest-bearing securities and assets
23.14%Limit 30%Pass
Dividend purification
2.88%Share of dividends to give to charityPurification calculator

Last updated: Oct 22, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Acadia Pharmaceuticals Inc. (ACAD). Current Akinda screening label: Halal.